EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Epicardial adipose tissue as target of the incretin-based therapies in cardio-metabolic pathologies: a narrative review

Andrea S K Pop, Maria D Dănilă iD, Silvia Giuchici, Darius G Buriman, Bogdan M Lolescu, Adrian Sturza, Danina M Muntean, Ana Lascu

Canadian Journal of Physiology and Pharmacology · 2025

DOI: 10.1139/cjpp-2024-0384 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Canadian Journal of Physiology and Pharmacology, 2025. Verfasst von Andrea S K Pop und 7 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School Medicine, "Victor Babeș" University of Medicine and Pharmacy of Timișoara, Timișoara, Romania. Hauptthemen laut MEDLINE: Incretins, Adipose Tissue, Pericardium, Cardiovascular Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 100 Literaturangaben. Gefördert von: “Victor Babeș” University of Medicine and Pharmacy of Timișoara, Romania.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The epicardial adipose tissue (EAT) serves in physiological conditions as a mechanical and thermal myocardial protective layer, as well as a readily available lipid-storage unit. In pathological conditions, EAT expansion becomes deleterious and is currently recognized as an independent risk factor for the progression of cardiovascular diseases. The EAT phenotypic shift from protective to pro-inflammatory/pro-oxidant is facilitated by the presence of metabolic diseases (obesity, metabolic syndrome, and diabetes), which further increase its expansion and dysregulation, favor the occurrence of complications (mainly atrial fibrillation), and promote progression towards heart failure. Glucagon-like peptide-1 (GLP-1) receptor agonists are novel antidiabetic medications belonging to the incretin class that have demonstrated efficacy beyond glycemic control, in terms of weight reduction and cardiorenal protection in patients with type 2 diabetes mellitus. The GLP-1 receptors and glucose-dependent insulinotropic polypeptide (GIP) receptors are expressed in the human EAT and are targeted by an increasing number of pharmacological agonists, with pleiotropic protective effects on EAT structure and function. Herein we review the literature characterizing the benefits of GLP-1 and GIP receptors activation by single and dual agonists with particular emphasis on their effects on EAT and highlight the role of incretin-based therapy for the management of cardiometabolic pathologies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IncretinsAdipose TissuePericardiumCardiovascular DiseasesMetabolic DiseasesHumansAnimalsGlucagon-Like Peptide-1 Receptor AgonistsHypoglycemic AgentsDiabetes Mellitus, Type 2Glucagon-Like Peptide-1 ReceptorReceptors, Gastrointestinal HormoneEpicardial Adipose Tissue

Stichwörter der Autor:innen

cardiovascular protectiondiabetesglucose-dependent insulinotropic polypeptideheart failureobesitysingle and dual receptor agonists

Substanzen

IncretinsGlucagon-Like Peptide-1 Receptor AgonistsHypoglycemic AgentsGlucagon-Like Peptide-1 Receptorgastric inhibitory polypeptide receptorReceptors, Gastrointestinal Hormone

Autor:innen und Institutionen

  • Doctoral School Medicine, "Victor Babeș" University of Medicine and Pharmacy of Timișoara, Timișoara, Romania.
  • Centre for Translational Research and Systems Medicine, "Victor Babeș" University of Medicine and Pharmacy of Timișoara, Timișoara, Romania.
  • Department of Functional Sciences - Chair of Pathophysiology, "Victor Babeș" University of Medicine and Pharmacy of Timișoara, Timișoara, Romania.
  • Institute of Cardiovascular Diseases, Timișoara, Romania.

ORCID-Profile: Maria D Dănilă

Förderung

  • “Victor Babeș” University of Medicine and Pharmacy of Timișoara, Romania

Zitieren

APA

Pop, A., Dănilă, M., Giuchici, S., Buriman, D., Lolescu, B., Sturza, A., Muntean, D., & Lascu, A. (2025). Epicardial adipose tissue as target of the incretin-based therapies in cardio-metabolic pathologies: a narrative review. Canadian Journal of Physiology and Pharmacology. https://doi.org/10.1139/cjpp-2024-0384

Vancouver

Pop A, Dănilă M, Giuchici S, Buriman D, Lolescu B, Sturza A, et al. Epicardial adipose tissue as target of the incretin-based therapies in cardio-metabolic pathologies: a narrative review. Canadian Journal of Physiology and Pharmacology. 2025. doi:10.1139/cjpp-2024-0384

BibTeX
@article{Pop2025,
  author = {Pop, Andrea S K and Dănilă, Maria D and Giuchici, Silvia and Buriman, Darius G and Lolescu, Bogdan M and Sturza, Adrian and Muntean, Danina M and Lascu, Ana},
  title = {Epicardial adipose tissue as target of the incretin-based therapies in cardio-metabolic pathologies: a narrative review},
  journal = {Canadian Journal of Physiology and Pharmacology},
  year = {2025},
  doi = {10.1139/cjpp-2024-0384}
}
Kostenlos starten →